Literature DB >> 1700959

Effect of FK 506 on spontaneous diabetes in BB rats.

N Murase1, I Lieberman, M A Nalesnik, D H Mintz, S Todo, A L Drash, T E Starzl.   

Abstract

From days 30-120 after birth, 59 BB rats were treated with water (n = 20) or FK 506 in intragastric doses of 1 mg.kg-1.day-1 (n = 19) or 2 mg.kg-1.day-1 (n = 20). Diabetes developed in 75, 15, and 0% of the 3 groups, respectively. Animals protected from diabetes by FK 506 had normal intraperitoneal glucose tolerance tests, virtual absence histopathologically of autoimmune insulitis, and normal pancreatic insulin content. Forty-five to 75 days after stopping FK 506, approximately 75% of the rats that were diabetes free at 120 days remained so.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700959      PMCID: PMC3022474          DOI: 10.2337/diab.39.12.1584

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Transplantation.

Authors:  T E Starzl; J J Fung
Journal:  JAMA       Date:  1990-05-16       Impact factor: 56.272

2.  Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

Authors:  N Murase; S Todo; P H Lee; H S Lai; F Chapman; M A Nalesnik; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors:  T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

4.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

5.  Liver, kidney, and thoracic organ transplantation under FK 506.

Authors:  S Todo; J J Fung; T E Starzl; A Tzakis; A J Demetris; R Kormos; A Jain; M Alessiani; S Takaya; R Shapiro
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

6.  Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

Authors:  A A Like; V Dirodi; S Thomas; D L Guberski; A A Rossini
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  Cyclosporin prevents diabetes in BB Wistar rats.

Authors:  A Laupacis; C R Stiller; C Gardell; P Keown; J Dupre; A C Wallace; P Thibert
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

8.  Prevention of diabetes in BB rats by intermittent administration of cyclosporine.

Authors:  K L Brayman; J Armstrong; L M Shaw; T G Rosano; J E Tomaszewski; C F Barker; A Naji
Journal:  Surgery       Date:  1987-08       Impact factor: 3.982

9.  Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.

Authors:  C R Stiller; J Dupré; M Gent; M R Jenner; P A Keown; A Laupacis; R Martell; N W Rodger; B von Graffenried; B M Wolfe
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

10.  Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.

Authors:  R Assan; G Feutren; M Debray-Sachs; M C Quiniou-Debrie; C Laborie; G Thomas; L Chatenoud; J F Bach
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

  10 in total
  6 in total

1.  The use of FK 506 in new-onset type I diabetes in man.

Authors:  P B Carroll; A G Tzakis; C Ricordi; H R Rilo; K Abu-Elmagd; N Murase; Y J Zeng; R Alejandro; D Mintz; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice.

Authors:  W L Baeder; J Sredy; S N Sehgal; J Y Chang; L M Adams
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 3.  Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?

Authors:  Francesca M Egidi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Post-transplant diabetes mellitus. The role of immunosuppression.

Authors:  R M Jindal; R A Sidner; M L Milgrom
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

5.  Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice.

Authors:  R Calafiore; G Basta; A Falorni; M Pietropaolo; M L Picchio; F Calcinaro; P Brunetti
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

6.  The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin.

Authors:  G Papaccio; M Latronico; G Chieffi Baccari
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.